Observational study of heart failure patients in Vietnam

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to collect and analyze demographic, clinical, biological, and treatment characteristics of patients diagnosed with heart failure in Vietnam. It will follow patients discharged with heart failure with reduced or mildly reduced ejection fraction, gathering data at the time of discharge and at 1, 3, and 12 months post-discharge. The study will utilize standardized data definitions to ensure consistency and accuracy in data collection, focusing on various clinical outcomes and treatment responses. The information will be gathered through direct communication with patients and recorded using the REDCap system.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged 18 years and older
* Diagnosed with heart failure at the time of discharge
* Have an ejection fraction (based on imaging modalities such as echocardiography or cardiac MRI) recorded closest to the time of discharge, showing a left ventricular ejection fraction of less than 50%

Exclusion Criteria:

* Patients and their relatives do not have means of communication with healthcare staff (phone, computer, messaging, etc.)
* Patients do not reside in Vietnam after discharge

Where it's running

• University Medical Center Ho Chi Minh City
  Ho Chi Minh City, Vietnam Recruiting

Study contacts

• Principal investigator: Hoang Vu Vu, PhD — University of Medicine and Pharmacy at Ho Chi Minh City
• Study coordinator: Hoang Vu Vu, MD, PhD
• Email: vu.vh@umc.edu.vn
• Phone: +84908431304

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pulmonary Artery Denervation for a specific type of heart and lung pressure problem

  This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.

  Recruiting at 18 sites Pulnovo Medical, Inc. · Tucson, Arizona and 18 other locations · NCT07214376

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Stepwise withdrawal of ARNI and SGLT2i in HF with normalized ejection fraction

  This trial tests whether gradually stopping ARNI and SGLT2i is safe for people whose heart function has recovered after fixing a reversible heart‑disease cause.

  Recruiting Phase 4 Keimyung University Dongsan Medical Center · Daegu, Daegu and 4 other locations · NCT07631156

• Using omecamtiv mecarbil to treat chronic heart failure with severely reduced ejection fraction

  This study is testing if a new drug called omecamtiv mecarbil can help people with severe chronic heart failure live longer and avoid serious heart problems.

  Recruiting at 205 sites Phase 3 Cytokinetics · Alexander City, Alabama and 212 other locations · NCT06736574

• Diet-management app and smart scale for weight loss in people with heart failure and obesity

  This tests whether using a diet-management phone app at each meal plus a smart weight scale daily for 12 months helps people with heart failure and obesity live longer, avoid hospital stays, and feel less frail.

  Recruiting at 19 sites Heart Health Research Center · Beijing, Beijing Municipality and 25 other locations · NCT06455878

• Using colchicine to treat acutely decompensated heart failure with reduced ejection fraction

  This study is testing if colchicine, an anti-inflammatory medication, can help people in the hospital with heart failure feel better and improve their heart function.

  Recruiting Phase 4 University of Virginia · Charlottesville, Virginia · NCT06286423

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.